{"id":299,"date":"2011-10-26T12:30:00","date_gmt":"2011-10-26T12:30:00","guid":{"rendered":"https:\/\/nolato.wpengine.com\/?mfn_news=continued-good-development-and-strong-financial-position"},"modified":"2011-10-26T12:30:00","modified_gmt":"2011-10-26T12:30:00","slug":"continued-good-development-and-strong-financial-position","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/ru\/mfn_news\/continued-good-development-and-strong-financial-position\/","title":{"rendered":"Continued good development and strong financial position"},"content":{"rendered":"<div class=\"mfn-preamble\"><strong><\/strong><\/div>\n<p><span>In today\u2019s nine-month interim report for 2011, Nolato reports good growth for Nolato Medical and Nolato Industrial, while Nolato Telecom continues to record weak volumes.<\/span><\/p>\n<p><span>\u201cThe EBITA margin for the third quarter was 7.5%, whilst the return on capital employed was 15%. These figures are almost on a par with the long-term profitability targets of 8% and 15% respectively,\u201d notes Nolato\u2019s CEO Hans Porat. <\/span><\/p>\n<p><span>The Group\u2019s sales amounted to SEK 718 million (887), operating income EBITA to SEK 54 million (67) and earnings per share to SEK 1.37 (1.78). <\/span><\/p>\n<p><span>Nolato Medical increased its sales by 9% to SEK 220 million (202). The operating income EBITA was SEK 25 million (25). <\/span><\/p>\n<p><span>\u201cVolumes remained good during the quarter and in line with market growth,\u201d says Hans Porat. To facilitate further expansion within Nolato Medical, we have decided to extend the production facility in Hungary by 3,500 square metres. <\/span><\/p>\n<p><span>Nolato Telecom\u2019s sales halved to SEK 220 million (444), including the resale of touch screens of approx. SEK 5 million (60). Operating income was SEK 7 million (32). <\/span><\/p>\n<p><span>\u201cDemand for the existing product portfolio within the mobile phone sector remained weak,\u201d comments Hans Porat. <\/span><\/p>\n<p><span>Nolato Industrial\u2019s sales rose by 16% to SEK 279 million (241), and the operating income EBITA increased by 24% to SEK 26 million (21). <\/span><\/p>\n<p><span>\u201cDemand has remained strong and has increased within most customer segments,\u201d says Hans Porat. As we announced previously, a small production facility has been established in Romania and production there is proceeding as planned. <\/span><\/p>\n<p><span>Nolato\u2019s financial position remains strong. At the end of the third quarter, net debt was SEK 66 million (199), and the equity\/assets ratio was 52% (48). Cash flow for the nine months of 2011 amounted to SEK 123 million (75, excluding acquisitions).<\/span><\/p>\n<div class=\"mfn-footer\">\n<p><span><em>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/><\/em><\/span><span><em>For further information, please contact:\u00a0<br \/><\/em><\/span><span><em>Hans Porat, President and CEO, telephone 46 431 442294\u00a0<\/em><\/span><br \/><span><em>Per-Ola Holmstr\u00f6m, Executive Vice President and CFO, telephone 46 431 442293<\/em><\/span><\/p>\n<\/p>\n<p><span><em>Nolato AB discloses the information provided herein pursuant to the Securities Markets Act and\/or the Financial Instruments Trading Act. The information was submitted for publication at 2,30 pm on 26 October 2011.<\/em><\/span><\/p>\n<p><span><em><br \/><\/em><\/span><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>In today\u2019s nine-month interim report for 2011, Nolato reports good growth for Nolato Medical and Nolato Industrial, while Nolato Telecom continues to record weak volumes. \u201cThe EBITA margin for the third quarter was 7.5%, whilst the return on capital employed was 15%. These figures are almost on a par with the long-term profitability targets of&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/ru\/mfn_news\/continued-good-development-and-strong-financial-position\/\">Continue reading <span class=\"screen-reader-text\">Continued good development and strong financial position<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-299","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-listing","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"ru","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/ru\/wp-json\/wp\/v2\/mfn_news\/299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/ru\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/ru\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/ru\/wp-json\/wp\/v2\/media?parent=299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}